ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 311,83
-0,91%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Krystal Biotech Inc (KRYS)

  7. Krystal Biotech Inc (KRYS) Actualités

KRYS Krystal Biotech Inc

161,10
0,87 (0,54%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Krystal Biotech Inc KRYS NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,87 0,54% 161,10 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
163,55 157,895 164,74 161,10 160,23
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202413:00GLOBEKrystal Biotech to Present at the Association for Research..
26/4/202413:00GLOBEKrystal Biotech to Report First Quarter 2024 Financial..
22/4/202413:00GLOBEKrystal Biotech Announces First Patient Dosed in Phase 1..
04/4/202413:00GLOBEKrystal Biotech to Present at the American Association..
02/3/202402:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202402:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202403:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202413:00GLOBEKrystal Biotech to Present at TD Cowen 44th Annual Health..
26/2/202419:35EDGAR2Form 144 - Report of proposed sale of securities
26/2/202414:04EDGAR2Form 8-K - Current report
26/2/202414:00GLOBEKrystal Biotech Announces Fourth Quarter and Full Year 2023..
26/2/202413:59EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/2/202413:49EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/2/202411:57IHMARKETNEWSU.S. Index Futures Dip Amid Inflation Data Anticipation, Oil..
20/2/202413:00GLOBEKrystal Biotech to Report Fourth Quarter and Full Year 2023 ..
13/2/202413:00GLOBEKrystal Biotech Receives FDA Fast Track Designation for..
08/2/202413:00GLOBEKrystal Biotech Announces Publication in the New England..
01/2/202413:00GLOBEKrystal Biotech to Present at Guggenheim 6th Annual..
24/1/202423:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202417:43EDGAR2Form 144 - Report of proposed sale of securities
04/1/202413:00GLOBEKrystal Biotech Receives Permanent J-code (J3401) for..
19/12/202313:00GLOBEKrystal Biotech Receives Orphan Drug Designation from the..
27/11/202313:00GLOBEKrystal Biotech Announces EMA Validation of Marketing..
09/11/202313:00GLOBEKrystal Biotech to Present at the Stifel 2023 Healthcare..
06/11/202313:10EDGAR2Form 8-K - Current report
06/11/202313:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202313:00GLOBEKrystal Biotech Announces Third Quarter 2023 Financial..
30/10/202312:00GLOBEKrystal Biotech to Report Third Quarter 2023 Financial..
02/10/202318:07EDGAR2Form 144 - Report of proposed sale of securities
28/9/202313:00GLOBEKrystal Biotech to Present at the Chardan 7th Annual Genetic..
07/9/202313:00GLOBEKrystal Biotech to Present at the Morgan Stanley 21st Annual..
05/9/202313:00GLOBEKrystal Biotech Announces Orphan Drug Designation Granted to..
21/8/202323:30EDGAR2Form 144 - Report of proposed sale of securities
16/8/202322:57EDGAR2Form 144 - Report of proposed sale of securities
15/8/202322:56EDGAR2Form 144 - Report of proposed sale of securities
11/8/202322:39EDGAR2Form 144 - Report of proposed sale of securities
11/8/202300:06EDGAR2Form 144 - Report of proposed sale of securities
07/8/202314:18EDGAR2Form 8-K - Current report
07/8/202313:13EDGAR2Form 8-K - Current report
07/8/202313:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202313:00GLOBEKrystal Biotech Announces Second Quarter 2023 Financial..
26/7/202322:14GLOBEKrystal Biotech Announces Pipeline Expansion into Oncology..
26/7/202322:01EDGAR2Form 8-K - Current report
18/7/202322:05EDGAR2Form S-3ASR - Automatic shelf registration statement of..
10/7/202322:01GLOBEArbutus Appoints Two New Executives
03/7/202322:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202322:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202313:00GLOBEKrystal Biotech Announces First Patient Dosed in Phase 1..
05/6/202313:00GLOBEKrystal Biotech to Present at Upcoming Investor Conferences

Dernières Valeurs Consultées

NASDAQ
KRYS
Krystal Biotech
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés